Figure 3
Forest plot depicting the efficacy outcomes of PCSK9 monoclonal antibody on familial hypercholesterolemia and statin-intolerant patients.
Figure 3 | Scientific Reports
Forest plot depicting the efficacy outcomes of PCSK9 monoclonal antibody on familial hypercholesterolemia and statin-intolerant patients.
